Connection

Mitzi Nagarkatti to Antigens, Differentiation, Myelomonocytic

Back to Details
This is a "connection" page, showing publications Mitzi Nagarkatti has written about Antigens, Differentiation, Myelomonocytic.
Mitzi Nagarkatti
Connection Strength
0.040
Antigens, Differentiation, Myelomonocytic
  1. Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21. Am J Physiol Gastrointest Liver Physiol. 2019 10 01; 317(4):G408-G428.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.